Merck & Co., Inc. Halts Animal-Drug Sale After Cattle Walking Problem

Published: Aug 19, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Merck & Co. (MRK) will suspend sales of its livestock-feed supplement Zilmax in the U.S. and Canada after cattle taking it had trouble walking or standing. The sales halt is temporary while the company plans a study of the drug, Whitehouse Station, New Jersey-based Merck said today in a statement. The drugmaker, which sells veterinary and farm products in more than 140 countries, generated $3.4 billion last year from its animal health business.

Help employers find you! Check out all the jobs and post your resume.

Back to news